Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Spring Sale
Enjoy this offer
* See conditions under "Our services"

Valuation: Sandoz Group AG

Capitalization 33.94B 29.39B 26.53B 25.35B 46.16B 3,129B 47.6B 313B 125B 1,497B 127B 125B 5,396B P/E ratio 2026 *
26x
P/E ratio 2027 * 20.9x
Enterprise value 37.11B 32.14B 29B 27.72B 50.47B 3,421B 52.04B 342B 136B 1,636B 139B 136B 5,900B EV / Sales 2026 *
3.07x
EV / Sales 2027 * 2.87x
Free-Float
95.68%
Yield 2026 *
1.27%
Yield 2027 * 1.58%
1 day-3.50%
1 week-6.48%
Current month-10.03%
1 month-1.89%
3 months+3.55%
6 months+26.97%
Current year+5.81%
1 week 60.94
Extreme 60.94
66.26
1 month 60.94
Extreme 60.94
72.7
Current year 56.94
Extreme 56.94
72.7
1 year 26.25
Extreme 26.25
72.7
3 years 22.7
Extreme 22.7
72.7
5 years 22.7
Extreme 22.7
72.7
10 years 22.7
Extreme 22.7
72.7
Manager TitleAgeSince
Chief Executive Officer 59 31/12/2018
Director of Finance/CFO 58 30/06/2024
Chief Tech/Sci/R&D Officer 59 31/05/2025
Director TitleAgeSince
Director/Board Member 63 31/07/2023
Chairman 66 28/02/2023
Director/Board Member 61 31/07/2023
Change 5d. change 1-year change 3-years change Capi.($)
-3.50%-6.48%+67.67% - 35.35B
-0.15%-0.78%+20.50%+217.39% 895B
-0.30%-1.52%+44.90%+60.27% 587B
+0.30%-2.64%+5.09%+52.08% 401B
-1.55%-7.15%+7.35%+25.17% 345B
-0.62%-4.08%+19.59%+62.48% 300B
-1.16%-3.00%+22.31%+35.39% 306B
-0.75%-3.02%+22.03%+7.91% 289B
+0.59%+0.17%+15.36%+65.73% 202B
-1.72%-1.24%+24.56%+83.65% 184B
Average -0.58%-2.11%+24.94%+67.78% 354.58B
Weighted average by Cap. -0.30%-1.92%+22.11%+91.17%

Financials

2026 *2027 *
Net sales 12.11B 10.48B 9.46B 9.04B 16.46B 1,116B 16.97B 112B 44.48B 534B 45.42B 44.46B 1,924B 12.64B 10.95B 9.88B 9.44B 17.19B 1,165B 17.72B 117B 46.45B 557B 47.43B 46.43B 2,010B
Net income 1.36B 1.18B 1.06B 1.02B 1.85B 125B 1.91B 12.54B 4.99B 59.91B 5.1B 4.99B 216B 1.65B 1.43B 1.29B 1.23B 2.24B 152B 2.31B 15.21B 6.05B 72.64B 6.18B 6.05B 262B
Net Debt 3.17B 2.74B 2.48B 2.37B 4.31B 292B 4.44B 29.23B 11.64B 140B 11.89B 11.63B 504B 2.39B 2.07B 1.86B 1.78B 3.24B 220B 3.35B 22.02B 8.77B 105B 8.95B 8.76B 379B
Logo Sandoz Group AG
Sandoz Group AG is a Switzerland based company which is active in healthcare technology industry. The Company operates in two businesses, Generics and Biosimilars. Generics business develops, manufacture and market active ingredients and finished dosage forms of small molecule pharmaceuticals, finished dosage forms of anti-infectives and active pharmaceutical ingredients and intermediates. Biosimilars business develops, manufacture and market protein-based and other biological products which are similar to another already approved biological medicines. Company’s product portfolio comprising Generics and Biosimilars covers all therapeutic areas for patient treatment such as cardiovascular, central nervous system, oncology, anti-infectives, pain and respiratory. The Company serves customers worldwide.
Employees
22,356
Date Price Change Volume
11/03/26 61.20 CHF -3.50% 1,306,605
10/03/26 63.42 CHF -0.81% 1,019,736
09/03/26 63.94 CHF +0.72% 776,390
06/03/26 63.48 CHF -1.82% 920,854
05/03/26 64.66 CHF -2.62% 796,650
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
78.45USD
Average target price
82.01USD
Spread / Average Target
+4.54%

Quarterly revenue - Rate of surprise

SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW